Skip to main content
construction release_alert
Scholars@Duke will be down for maintenance for approximately one hour starting Tuesday, 11/11 @1pm ET
cancel
Journal cover image

Functional analysis of low-grade glioma genetic variants predicts key target genes and transcription factors.

Publication ,  Journal Article
Manjunath, M; Yan, J; Youn, Y; Drucker, KL; Kollmeyer, TM; McKinney, AM; Zazubovich, V; Zhang, Y; Costello, JF; Eckel-Passow, J; Selvin, PR ...
Published in: Neuro Oncol
April 12, 2021

BACKGROUND: Large-scale genome-wide association studies (GWAS) have implicated thousands of germline genetic variants in modulating individuals' risk to various diseases, including cancer. At least 25 risk loci have been identified for low-grade gliomas (LGGs), but their molecular functions remain largely unknown. METHODS: We hypothesized that GWAS loci contain causal single nucleotide polymorphisms (SNPs) that reside in accessible open chromatin regions and modulate the expression of target genes by perturbing the binding affinity of transcription factors (TFs). We performed an integrative analysis of genomic and epigenomic data from The Cancer Genome Atlas and other public repositories to identify candidate causal SNPs within linkage disequilibrium blocks of LGG GWAS loci. We assessed their potential regulatory role via in silico TF binding sequence perturbations, convolutional neural network trained on TF binding data, and simulated annealing-based interpretation methods. RESULTS: We built an interactive website (http://education.knoweng.org/alg3/) summarizing the functional footprinting of 280 variants in 25 LGG GWAS regions, providing rich information for further computational and experimental scrutiny. We identified as case studies PHLDB1 and SLC25A26 as candidate target genes of rs12803321 and rs11706832, respectively, and predicted the GWAS variant rs648044 to be the causal SNP modulating ZBTB16, a known tumor suppressor in multiple cancers. We showed that rs648044 likely perturbed the binding affinity of the TF MAFF, as supported by RNA interference and in vitro MAFF binding experiments. CONCLUSIONS: The identified candidate (causal SNP, target gene, TF) triplets and the accompanying resource will help accelerate our understanding of the molecular mechanisms underlying genetic risk factors for gliomas.

Duke Scholars

Published In

Neuro Oncol

DOI

EISSN

1523-5866

Publication Date

April 12, 2021

Volume

23

Issue

4

Start / End Page

638 / 649

Location

England

Related Subject Headings

  • Transcription Factors
  • Polymorphism, Single Nucleotide
  • Oncology & Carcinogenesis
  • Nerve Tissue Proteins
  • Intracellular Signaling Peptides and Proteins
  • Humans
  • Glioma
  • Genome-Wide Association Study
  • Genetic Predisposition to Disease
  • Calcium-Binding Proteins
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Manjunath, M., Yan, J., Youn, Y., Drucker, K. L., Kollmeyer, T. M., McKinney, A. M., … Song, J. S. (2021). Functional analysis of low-grade glioma genetic variants predicts key target genes and transcription factors. Neuro Oncol, 23(4), 638–649. https://doi.org/10.1093/neuonc/noaa248
Manjunath, Mohith, Jialu Yan, Yeoan Youn, Kristen L. Drucker, Thomas M. Kollmeyer, Andrew M. McKinney, Valter Zazubovich, et al. “Functional analysis of low-grade glioma genetic variants predicts key target genes and transcription factors.Neuro Oncol 23, no. 4 (April 12, 2021): 638–49. https://doi.org/10.1093/neuonc/noaa248.
Manjunath M, Yan J, Youn Y, Drucker KL, Kollmeyer TM, McKinney AM, et al. Functional analysis of low-grade glioma genetic variants predicts key target genes and transcription factors. Neuro Oncol. 2021 Apr 12;23(4):638–49.
Manjunath, Mohith, et al. “Functional analysis of low-grade glioma genetic variants predicts key target genes and transcription factors.Neuro Oncol, vol. 23, no. 4, Apr. 2021, pp. 638–49. Pubmed, doi:10.1093/neuonc/noaa248.
Manjunath M, Yan J, Youn Y, Drucker KL, Kollmeyer TM, McKinney AM, Zazubovich V, Zhang Y, Costello JF, Eckel-Passow J, Selvin PR, Jenkins RB, Song JS. Functional analysis of low-grade glioma genetic variants predicts key target genes and transcription factors. Neuro Oncol. 2021 Apr 12;23(4):638–649.
Journal cover image

Published In

Neuro Oncol

DOI

EISSN

1523-5866

Publication Date

April 12, 2021

Volume

23

Issue

4

Start / End Page

638 / 649

Location

England

Related Subject Headings

  • Transcription Factors
  • Polymorphism, Single Nucleotide
  • Oncology & Carcinogenesis
  • Nerve Tissue Proteins
  • Intracellular Signaling Peptides and Proteins
  • Humans
  • Glioma
  • Genome-Wide Association Study
  • Genetic Predisposition to Disease
  • Calcium-Binding Proteins